Prophylactic Rifaximin Decreases Post-TIPS Hepatic Encephalopathy
Evidence-Based GI: An ACG Publication and Podcast - Een podcast door American College of Gastroenterology - Woensdagen
Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi FACG discusses “The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial,” by Bureau et al, published in Ann Intern Med [2021 May;174(5):633-640].https://pubmed.ncbi.nlm.nih.gov/33524293/
